MBIO

Conviction 0HealthcareScan · Fri, Jun 26, 2026

Bullish belt hold

MBIO$0.6969+3.97%

ResistanceSupportVol 14

Vol MA14 80.18K

Mar 27Apr 15May 4May 20Jun 9Jun 26

MUSTANG BIO, INC.PHARMACEUTICAL PREPARATIONSwww.mustangbio.com ↗

Price0.6969

Change+3.97%

Gap+1.15%

Rel volume0.08×

Avg volume329.71K

Avg $ vol225.04K

SMA 200.7136

SMA 500.7036

SMA 2001.04

Price vs 50-0.95%

Price vs 200-33.07%

MA stackbearish

50/200 cross—

Supertrendup · 0.6021

RSI (14)49

MACD hist-0.00

MACD crossbear · 5d

Stoch %K / %D31 / 27

ADX (14)21

+DI / −DI23 / 16

RSI divergenceBearish

MACD divergence—

ATR %+9.25%

ADR %10.80%

52w high3.34

52w low0.5979

From 52w high-79.13%

Above 52w low+16.56%

New 52w highNo

SqueezeOn · 4d

Bollinger width21.38%

%B0.39

Donchian pos30.53%

Donchian high0.8480

Donchian low0.6305

AVWAP (52w high)4.02

vs AVWAP high-82.64%

AVWAP (52w low)0.7117

vs AVWAP low-2.08%

OBV trendDown

Chaikin MF (20)-0.74

Today vs 20d0.08×

Avg vol (14d)80.18K

Avg vol (20d)329.71K

Avg $ vol (20d)225.04K

Market cap—

RS 3m (vs SPY)-24.18%

RS 6m (vs SPY)-46.84%

RS line new highNo

Trend template0/8

Technical rank30.0

1 week+7.22%

1 month+9.32%

3 months-5.82%

6 months-32.99%

1 year-32.34%

YTD-34.87%

P/E-8.76

P/B1.96

P/S—

P/FCF-3.20

EPS-0.3900

Div yield—

ROE-22.35%

ROA-11.58%

Debt/Eq0.00

Current2.25

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth87.80%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value576.02K

Revenue—

Net income-955K

Gross profit—

Free cash flow-5.26M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out6.73M

Employees4

ListedTue, Aug 22, 2017

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank30.0 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish belt hold

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MBIO

All disclosures →

No recent disclosed trades by Congress in MBIO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MBIO · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Litchman Manuel MD President, CEO and Interim CFO · COMMON STOCK · 2026-04-24	Tax	19	$14	2026-04-24	2026-04-27

SEC filings

EDGAR filings in MBIO

EDGAR →

No recent SEC filings on file for MBIO.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.